Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:protein
|
| gptkbp:application |
understanding developmental biology
understanding genetic mutations development of diagnostic tools development of therapeutic strategies study of neurodegenerative diseases study of cancer biology study of cell adhesion study of muscular dystrophies understanding cell signaling pathways understanding extracellular matrix dynamics understanding glycoprotein functions understanding immunology understanding muscle regeneration understanding neuronal repair understanding protein-protein interactions understanding regenerative medicine understanding stem cell biology understanding tissue engineering understanding virology |
| gptkbp:associated_with |
muscle tissue
|
| gptkbp:clinical_trial |
target for gene therapy
biomarker for muscular dystrophies involved in cancer progression involved in viral infections |
| gptkbp:diseases |
gptkb:muscular_dystrophy
Walker-Warburg syndrome |
| gptkbp:function |
cell adhesion
|
| https://www.w3.org/2000/01/rdf-schema#label |
dystroglycan
|
| gptkbp:interacts_with |
dystrophin
|
| gptkbp:involved_in |
dystrophin-glycoprotein complex
|
| gptkbp:is_expressed_in |
gptkb:Brain
gptkb:Heart skeletal muscle |
| gptkbp:location |
plasma membrane
|
| gptkbp:modifications |
glycosylation
|
| gptkbp:orthologs |
DAG1 in humans
DAG1 in mice DAG1 in rats DAG1 in zebrafish |
| gptkbp:pathway |
cell signaling
muscle development neuronal development extracellular matrix interaction |
| gptkbp:promoter |
DAG1
|
| gptkbp:role |
neuromuscular junction
|
| gptkbp:subunit |
alpha dystroglycan
beta dystroglycan |
| gptkbp:type |
glycoprotein
|
| gptkbp:bfsParent |
gptkb:CMD_with_dystroglycanopathy
|
| gptkbp:bfsLayer |
6
|